Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Operating Expenses (2016 - 2025)

Prestige Consumer Healthcare has reported Operating Expenses over the past 16 years, most recently at $74.9 million for Q4 2025.

  • Quarterly results put Operating Expenses at $74.9 million for Q4 2025, up 8.38% from a year ago — trailing twelve months through Dec 2025 was $296.9 million (up 3.91% YoY), and the annual figure for FY2025 was $297.7 million, up 5.56%.
  • Operating Expenses for Q4 2025 was $74.9 million at Prestige Consumer Healthcare, up from $71.9 million in the prior quarter.
  • Over the last five years, Operating Expenses for PBH hit a ceiling of $434.8 million in Q1 2023 and a floor of $63.2 million in Q4 2022.
  • Median Operating Expenses over the past 5 years was $71.8 million (2023), compared with a mean of $90.0 million.
  • Biggest five-year swings in Operating Expenses: soared 508.59% in 2023 and later tumbled 83.98% in 2024.
  • Prestige Consumer Healthcare's Operating Expenses stood at $72.5 million in 2021, then fell by 12.76% to $63.2 million in 2022, then increased by 12.48% to $71.1 million in 2023, then decreased by 2.84% to $69.1 million in 2024, then rose by 8.38% to $74.9 million in 2025.
  • The last three reported values for Operating Expenses were $74.9 million (Q4 2025), $71.9 million (Q3 2025), and $68.6 million (Q2 2025) per Business Quant data.